PTC Therapeutics Inc
XMUN:BH3
PTC Therapeutics Inc
XMUN:BH3
Price:
61
EUR
1.33%
Market Closed
Market Cap:
€4.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PTC Therapeutics Inc
XMUN:BH3
|
US |
|
C
|
CF Industries Holdings Inc
F:C4F
|
US |
|
Odfjell Drilling Ltd
F:OD3
|
BM |
|
TechnoPro Holdings Inc
F:30T
|
JP |
|
Virgin Galactic Holdings Inc
F:0QL
|
US |
|
C
|
CF Industries Holdings Inc
XMUN:C4F
|
US |
|
A
|
ASM International NV
F:AVS
|
NL |
Wall St Price Targets
BH3 Price Targets Summary
PTC Therapeutics Inc
PTC Therapeutics Inc
Wall Street analysts forecast BH3 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for BH3 is 88.83 EUR with a low forecast of 62.58 EUR and a high forecast of 120.82 EUR.
Lowest Forecast
Price Target
62.58
EUR
3% Upside
Average Forecast
Price Target
88.83
EUR
46% Upside
Highest Forecast
Price Target
120.82
EUR
98% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
88.83
EUR
88.83
EUR
According to Wall Street analysts, the average 1-year price target for BH3 is 88.83 EUR with a low forecast of 62.58 EUR and a high forecast of 120.82 EUR.
